Structures of P-falciparum protein kinase 7 identify an activation motif and leads for inhibitor design

被引:58
作者
Merckx, Anais [1 ,2 ,3 ]
Echalier, Aude [1 ]
Langford, Kia [1 ]
Sicard, Audrey
Langsley, Gordon [2 ,3 ]
Joore, Jos [5 ]
Doerig, Christian [4 ]
Noble, Martin [1 ]
Enclicott, Jane [1 ]
机构
[1] Univ Oxford, Mol Biophys Lab, Dept Biochem, Oxford OX1 3QU, England
[2] Univ Paris 06, CNRS, Inst Cochin, UMR 8104, Paris, France
[3] INSERM U567, Paris, France
[4] INSERM U609, Wellcome Ctr Mol Parasitol, Glasgow biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[5] Pepscan Syst BV, NL-8219 PH Lelystad, Netherlands
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.str.2007.11.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malaria is a major threat to world health. The identification of parasite targets for drug development is a priority and parasitic protein kinases suggest themselves as suitable targets as many display profound structural and functional divergences from their host counterparts. In this paper, we describe the structure of the orphan protein kinase, Plasmodium falciparum protein kinase 7 (PFPK7). Several Plasmodium protein kinases contain extensive insertions, and the structure of PFPK7 reveals how these may be accommodated as excursions from the canonical eukaryotic protein kinase fold. The constitutively active conformation of PFPK7 is stabilized by a structural motif in which the role of the conserved phosphorylated residue that assists in structuring the activation loop of many protein kinases is played by an arginine residue. We identify two series of PFPK7 ATP-competitive inhibitors and suggest further developments for the design of selective and potent PFPK7 lead compounds as potential antimalarials.
引用
收藏
页码:228 / 238
页数:11
相关论文
共 51 条
[1]   A genomic perspective of protein kinases in Plasmodium falciparum [J].
Anamika ;
Srinivasan, N ;
Krupa, A .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 58 (01) :180-189
[2]  
[Anonymous], [No title captured]
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[5]   Bringing kinases into focus: Efficient drug design through the use of chemogenomic toolkits [J].
Birault, Veronique ;
Harris, C. John ;
Le, Joelle ;
Lipkin, Mike ;
Nerella, Ravi ;
Stevens, Adrian .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (15) :1735-1748
[6]   A chemical switch for inhibitor-sensitive alleles of any protein kinase [J].
Bishop, AC ;
Ubersax, JA ;
Petsch, DT ;
Matheos, DP ;
Gray, NS ;
Blethrow, J ;
Shimizu, E ;
Tsien, JZ ;
Schultz, PG ;
Rose, MD ;
Wood, JL ;
Morgan, DO ;
Shokat, KM .
NATURE, 2000, 407 (6802) :395-401
[7]   Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach [J].
Bishop, AC ;
Kung, CY ;
Shah, K ;
Witucki, L ;
Shokat, KM ;
Liu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (04) :627-631
[8]   Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase [J].
Bullock, AN ;
Debreczeni, JÉ ;
Fedorov, OY ;
Nelson, A ;
Marsden, BD ;
Knapp, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7604-7614
[9]   Crystal structure of aurora-2, an oncogenic serine/threonine kinase [J].
Cheetham, GMT ;
Knegtel, RMA ;
Coll, JT ;
Renwick, SB ;
Swenson, L ;
Weber, P ;
Lippke, JA ;
Austen, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42419-42422
[10]   Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase [J].
Chen, Yueqin ;
Jirage, Dayadevi ;
Caridha, Diana ;
Kathcart, April K. ;
Cortes, Edison A. ;
Dennull, Richard A. ;
Geyer, Jeanne A. ;
Prigge, Sean T. ;
Waters, Norman C. .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2006, 149 (01) :48-57